Administration, Intranasal < Administration, Intravenous < Administration, Ophthalmic

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by Administration, Intravenous

Number of relevant bibliographic references: 14.

Ident.	Authors (with country if any)	Title
000867 (2019)	Paul Emery [Royaume-Uni] ; Juan Rondon [États-Unis] ; Janie Parrino [États-Unis] ; Yong Lin [États-Unis] ; Claudia Pena-Rossi [États-Unis] ; Hubert Van Hoogstraten [États-Unis] ; Neil M H. Graham [États-Unis] ; Nancy Liu [États-Unis] ; Anne Paccaly [États-Unis] ; Richard Wu [États-Unis] ; Alberto Spindler [Argentine]	Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis.
000870 (2019)	Ching-Tsai Lin [Taïwan] ; Wen-Nan Huang [Taïwan] ; Chia-Wei Hsieh [Taïwan] ; Yi-Ming Chen [Taïwan] ; Der-Yuan Chen [Taïwan] ; Tsu-Yi Hsieh [Taïwan] ; Yi-Hsing Chen [Taïwan]	Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis - A three-year study in Taiwan.
000920 (2019)	Chun-Yan Wang ; Shao-Hua Guo ; Li-Ping Wang ; Hai-Li Shen	Refractory adult-onset Still disease treated by tocilizumab combined with methotrexate
000936 (2019)	Carl Richard Svasti-Salee [Royaume-Uni] ; Susan P. Mollan [Royaume-Uni] ; Ann W. Morgan [Royaume-Uni] ; Vanessa Quick [Royaume-Uni]	Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritis.
001092 (2018)	Chuanyin Sun ; Yingwan Luo [République populaire de Chine] ; Hongyan Tong [République populaire de Chine] ; Guanhua Xu ; Jin Lin	Usefulness of tocilizumab for treating rheumatoid arthritis with myelodysplastic syndrome: A case report and literature review.
001343 (2018)	Anandani Nellan [États-Unis] ; Cynthia M Lester Mccully ; Rafael Cruz Garcia ; Nalini Jayaprakash ; Brigitte C. Widemann ; Daniel W. Lee [États-Unis] ; Katherine E. Warren	Improved CNS exposure to tocilizumab after cerebrospinal fluid compared to intravenous administration in rhesus macaques.
001374 (2018)	Carla Bastida ; Virginia Ruiz-Esquide ; Mariona Pascal ; Aurelia H. M. De Vries Schultink ; Jordi Yagüe ; Raimon Sanmartí ; Alwin D. R. Huitema ; Dolors Soy	Fixed dosing of intravenous tocilizumab in rheumatoid arthritis. Results from a population pharmacokinetic analysis
001674 (2017)	Le-Feng Chen [République populaire de Chine] ; Ying-Qian Mo [République populaire de Chine] ; Jun Jing [République populaire de Chine] ; Jian-Da Ma [République populaire de Chine] ; Dong-Hui Zheng [République populaire de Chine] ; Lie Dai [République populaire de Chine]	Short-course tocilizumab increases risk of hepatitis B virus reactivation in patients with rheumatoid arthritis: a prospective clinical observation.
001725 (2017)	Hisham Abdallah [États-Unis] ; Joy C. Hsu [États-Unis] ; Peng Lu [États-Unis] ; Scott Fettner [États-Unis] ; Xiaoping Zhang [États-Unis] ; Wendy Douglass [Royaume-Uni] ; Min Bao [États-Unis] ; Lucy Rowell [Royaume-Uni] ; Gerd R. Burmester [Allemagne] ; Alan Kivitz [États-Unis]	Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.
001757 (2017)	Gerd R. Burmester [Allemagne] ; Ernest Choy [Royaume-Uni] ; Alan Kivitz [États-Unis] ; Atsushi Ogata [Japon] ; Min Bao [États-Unis] ; Akira Nomura [Japon] ; Stuart Lacey [Royaume-Uni] ; Jinglan Pei [États-Unis] ; William Reiss [États-Unis] ; Attila Pethoe-Schramm [Suisse] ; Navita L. Mallalieu [États-Unis] ; Thomas Wallace [États-Unis] ; Margaret Michalska [États-Unis] ; Herbert Birnboeck [Suisse] ; Kay Stubenrauch [Allemagne] ; Mark C. Genovese [États-Unis]	Low immunogenicity of tocilizumab in patients with rheumatoid arthritis.
001B01 (2016)	M. Philippart [Pays-Bas] ; J. Schmidt [Suisse] ; B. Bittner [Suisse]	Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens.
001C60 (2016)	Carolina Diez Morrondo [Espagne] ; Lucia Pantoja Zarza ; Jenaro Gra A Gil ; Jose Antonio Pinto Tasende ; Paula Dios Diez ; Juan Manuel Barja L Pez	Benefit of Tocilizumab Therapy for Adult-Onset Still Disease Complicated With Acute Respiratory Distress Syndrome.
002126 (2015)	Vijay U. Rao [États-Unis] ; Andrey Pavlov ; Micki Klearman ; David Musselman ; Jon T. Giles ; Joan M. Bathon ; Naveed Sattar ; Janet S. Lee	An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy.
002323 (2014)	Anshuman P. Malaviya [Royaume-Uni] ; Jo Ledingham [Royaume-Uni] ; Jill Bloxham [Royaume-Uni] ; Aisla Bosworth [Royaume-Uni] ; Maya Buch [Royaume-Uni] ; Ernest Choy [Royaume-Uni] ; Andrew Cope [Royaume-Uni] ; John Isaacs [Royaume-Uni] ; David Marshall [Royaume-Uni] ; Gary Wright [Royaume-Uni] ; Andrew J K. Ostör [Royaume-Uni]	The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Administration, Intravenous" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Administration, Intravenous" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Administration, Intravenous
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021